STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

ASP Isotopes Stock Price, News & Analysis

ASPI Nasdaq

Welcome to our dedicated page for ASP Isotopes news (Ticker: ASPI), a resource for investors and traders seeking the latest updates and insights on ASP Isotopes stock.

ASP Isotopes Inc. (ASPI) is a leader in advanced isotope enrichment technology, leveraging proprietary processes to address critical needs in healthcare, quantum computing, and clean energy. This page aggregates all official company announcements, press releases, and strategic updates.

Investors and industry professionals will find timely information on technology breakthroughs, facility expansions, and strategic partnerships. Content categories include earnings reports, R&D milestones, and applications of enriched isotopes in medical diagnostics, semiconductor manufacturing, and next-generation nuclear fuels.

Our curated news collection provides actionable insights into ASP Isotopes' operational progress and market positioning. Users benefit from streamlined access to verified updates, reducing research time while maintaining compliance with financial disclosure standards.

Bookmark this page for ongoing coverage of ASP Isotopes' innovations in aerodynamic separation and quantum enrichment technologies. Check regularly for developments shaping the future of isotope-dependent industries.

Rhea-AI Summary

ASP Isotopes (Nasdaq:ASPI) and Calidi Biotherapeutics (NYSE American:CLDI) will be featured on the RedChip Small Stocks, Big Money™ show on Bloomberg TV, airing May 25 at 7 p.m. ET. ASP Isotopes CEO Paul Mann will discuss the company's advancements in nuclear medicine and green nuclear energy, emphasizing its strong financial position with no long-term debt and significant cash reserves. H.C. Wainwright reaffirmed its buy rating, raising the price target to $5.50. Calidi Biotherapeutics CEO Allan Camaisa will highlight their cutting-edge oncolytic virotherapy (OV) treatments for cancer, showcasing promising initial study results and innovative IV-based technology for enhanced treatment efficacy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.95%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.89%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.79%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.44%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.03%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.17%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.17%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.22%
Tags
none

FAQ

What is the current stock price of ASP Isotopes (ASPI)?

The current stock price of ASP Isotopes (ASPI) is $6.165 as of November 24, 2025.

What is the market cap of ASP Isotopes (ASPI)?

The market cap of ASP Isotopes (ASPI) is approximately 661.7M.
ASP Isotopes

Nasdaq:ASPI

ASPI Rankings

ASPI Stock Data

661.72M
89.12M
22.39%
45.32%
16.81%
Chemicals
Miscellaneous Chemical Products
Link
United States
WASHINGTON